InvestorsHub Logo

DonDonDonDon

09/07/21 12:47 AM

#32984 RE: Itsmo #32980

If they truly are waiting on more data, why not directly express that to management?


Because the ACTIV-5 trial is providing the data. The government is producing their own data. They don't need management. If it were issues about manufacturing, commercialization, etc. then the company would likely know about it. The fact that the company has no idea likely means the FDA are waiting on the ACTIV-5 data.

10nisman

09/07/21 8:30 AM

#32997 RE: Itsmo #32980

Also there hasn’t been any insider sales past couple of weeks

If HGEN trades comfortably over $17 for a series of days you'll see some more Insider trades. Plus, the Company needs to sell its shares...